- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
13 Drugs Approved for Primary Care in 2023
Get a quick look at 13 of the many FDA-approved drugs in 2023 for conditions commonly seen in primary care.
With 2023 at an end, Patient Care Online has compiled a list of key drugs approved by the US Food and Drug Administration (FDA) for conditions that are often seen in primary care. Scroll through the slides below to find details on a novel GIP and GLP-1 hormone mimetic indicated for chronic weight management; the first nonprescription daily oral contraceptive to be approved to prevent pregnancy; the first respiratory syncytial virus (RSV) vaccine for older adults; the first anti-inflammatory atheroprotective therapy for cardiovascular disease; and 9 more.
Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1–Based Weight Loss
December 19th 2025Topline Phase 3 ATTAIN-MAINTAIN data show oral orforglipron met primary and key secondary endpoints for weight maintenance after prior GLP-1–based injectable therapy in adults with obesity.
